News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
265,732 Results
Type
Article (14400)
Company Profile (257)
Press Release (251075)
Section
Business (81689)
Career Advice (182)
Deals (13558)
Drug Delivery (29)
Drug Development (51184)
Employer Resources (33)
FDA (5807)
Job Trends (5314)
News (147866)
Policy (10504)
Tag
Academia (944)
Africa (168)
Allergies (30)
Alliances (22143)
Alzheimer's disease (706)
Antibody-drug conjugate (ADC) (31)
Approvals (5773)
Arizona (39)
Artificial intelligence (30)
Asia (17062)
Australia (2883)
Bankruptcy (107)
Best Places to Work (4526)
Biotechnology (215)
C2C Services and Suppliers (11969)
California (1239)
Canada (502)
Cancer (309)
Career advice (158)
CAR-T (34)
Cell therapy (96)
China (90)
Clinical research (39819)
Collaboration (90)
Colorado (39)
Compensation (40)
Connecticut (42)
COVID-19 (1057)
Cystic fibrosis (59)
Data (228)
Diabetes (38)
Diagnostics (1437)
Earnings (29412)
Employer resources (31)
Europe (37765)
Events (47006)
Executive appointments (99)
FDA (5929)
Florida (128)
Funding (99)
Gene editing (29)
Gene therapy (81)
GLP-1 (270)
Government (1168)
Healthcare (6724)
Hotbed/Location (189370)
Illinois (76)
Indiana (44)
Infectious disease (1069)
Inflammatory bowel disease (79)
IPO (7274)
Job creations (893)
Job search strategy (152)
Kansas (53)
Layoffs (180)
Legal (1449)
Lung cancer (70)
Manufacturing (29)
Maryland (189)
Massachusetts (1001)
Medical device (2627)
Medtech (2628)
Mergers & acquisitions (6280)
Metabolic disorders (133)
Michigan (38)
Minnesota (65)
Neuroscience (814)
New Jersey (335)
New York (401)
NextGen Class of 2024 (2082)
Non-profit (893)
North Carolina (333)
Northern California (538)
Obesity (76)
Ohio (63)
Opinion (88)
Parkinson's disease (31)
Patents (38)
Pennsylvania (277)
People (25202)
Pharmaceutical (41)
Phase I (13957)
Phase II (18545)
Phase III (11773)
Pipeline (78)
Postmarket research (858)
Preclinical (5861)
Press Release (30)
Rare diseases (103)
Real estate (1521)
Regulatory (8328)
Research institute (961)
South America (228)
Southern California (514)
Startups (1992)
Texas (117)
United States (4748)
Vaccines (160)
Washington State (155)
Weight loss (60)
Date
Today (58)
Last 7 days (395)
Last 30 days (1418)
Last 365 days (21800)
2024 (15340)
2023 (22806)
2022 (27534)
2021 (28624)
2020 (24096)
2019 (16965)
2018 (12301)
2017 (14196)
2016 (12247)
2015 (14820)
2014 (10712)
2013 (7724)
2012 (7733)
2011 (7845)
2010 (7613)
265,732 Results for "prime therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Prime Therapeutics hires industry veteran Mike Edwards to lead new market-focused organization
Prime Therapeutics, LLC/Magellan Rx Management announces the appointment of health care leader Mike Edwards as president, markets.
June 10, 2024
·
2 min read
Press Releases
Prime Therapeutics recognized at PBMI for award-winning solutions, leaders
September 6, 2024
·
3 min read
Business
Prime Therapeutics and Capital Rx Enter Into Transformative Strategic Alliance
Prime Therapeutics LLC/Magellan Rx Management, LLC (Prime), a leading pharmacy solutions organization, and Capital Rx, Inc. (Capital Rx), a renowned health care technology solutions provider, are announcing a strategic alliance.
March 13, 2024
·
4 min read
Genetown
Prime Medicine to Present at Upcoming Investor Conferences
Prime Medicine, Inc. today announced that Keith Gottesdiener, M.D., President and Chief Executive Officer will present at two upcoming investor conferences.
May 30, 2024
·
2 min read
BioMidwest
Prime Therapeutics and Magellan Rx present award-winning and industry-leading clinical insights at AMCP
Prime Therapeutics LLC / Magellan Rx Management, LLC continues to publish award-winning and industry-leading research on a range of clinical topics impacting the health care and pharmacy benefit management industry. Thought leaders from Prime/MRx will present eight research studies at the Academy of Managed Care Pharmacy (AMCP) Annual Meeting, April 15-18 in New Orleans.
April 11, 2024
·
3 min read
BioMidwest
Prime/MRx’s new Pharmacy Match technology-driven solution expands specialty pharmacy access and choice
Prime Therapeutics LLC and Magellan Rx Management launched Pharmacy Match, a technology-enabled specialty pharmacy solution designed to drive competition through an expanded specialty pharmacy network and to lower drug costs for plan sponsors.
June 19, 2024
·
4 min read
Genetown
Prime Medicine to Present Preclinical Data Demonstrating Broad Potential of Prime Editing Technology at Upcoming Scientific Meetings
Prime Medicine, Inc. today announced that the Company will present preclinical data highlighting the broad potential of its Prime Editing technology and supporting the advancement of its programs at the 3rd Annual LNP Formulation and Process Development Summit (Boston, April 29-May 2, 2024); the American Society of Cell & Gene Therapy 27th Annual Meeting.
April 23, 2024
·
7 min read
Genetown
Prime Medicine to Participate in the 27th Annual Milken Institute Global Conference
Prime Medicine, Inc. today announced that Keith Gottesdiener, M.D., President and Chief Executive Officer of Prime Medicine, will participate in a panel discussion at the 27th Annual Milken Institute Global Conference entitled “Things That Will Blow Your Mind.”
May 1, 2024
·
2 min read
BioCapital
Nanochon closes $4M Series Seed Prime
Nanochon, a Washington, DC-based orthopedic device biotech company has raised $4 million in its series seed prime fundraising round.
May 6, 2024
·
1 min read
Biotech Bay
10x Genomics Begins Commercial Shipments of Xenium Prime 5K Pan-Tissue and Pathways Panel
10x Genomics, Inc., a leader in single cell and spatial biology, announced that it has started shipping its new Xenium Prime 5K Pan-Tissue and Pathways panel.
June 20, 2024
·
5 min read
1 of 26,574
Next